نتایج جستجو برای: ifn therapy

تعداد نتایج: 685719  

Bashir Hajibeigi, Bita Behnava, Hassan Abolghasemi, Kamran Bagheri Lankarani, Maryam Keshvari, Pegah Karimi Elizee, Seyed-Moayed Alavian, Seyed-Vahid Tabatabaei, Seyyed Mohammad Miri,

Background: Hepatitis C virus (HCV) infection is the most common transfusion transmitted disease in poly-transfused patients worldwide. In this study we aimed to evaluate the effects of pegylated interferon alfa-2a (PEG-IFN A-2a) in reducing serum ALT and eradicating serum hepatitis C virus (HCV) RNA in HCV infected polytransfused thalassemic patients. Materials and Methods: A cohort of 51 HCV-...

2014
Reza Karbasi-Afshar

Interferon (IFN)-based therapy, the cornerstone for treatment of hepatitis C virus (HCV) infection, is generally considered to be the single most effective treatment strategy for this infection. Although most adverse effects of IFN therapy respond very well to the cessation of this drug, there are reports of serious irreversible adverse effects. This review article evaluates the adverse effects...

Journal: :Gut 2003
A B van Nunen B E Hansen D J Suh H F Löhr L Chemello H Fontaine J Heathcote B C Song H L A Janssen R A de Man S W Schalm

BACKGROUND AND AIMS Interferon (IFN) induced hepatitis B e antigen (HBeAg) seroconversion is durable in 80-90% of chronic hepatitis B patients. Preliminary reports on the durability of HBeAg seroconversion following lamivudine are contradictory. We investigated the durability of response following IFN, lamivudine, or IFN-lamivudine combination therapy in a meta-analysis of individual patient da...

Journal: :Molecular medicine reports 2013
Aimei Li Jun Qian Junming He Qingmeng Zhang Aixia Zhai Wuqi Song Yujun Li Hong Ling Zhaohua Zhong Fengmin Zhang

Type I interferon (IFN) is believed to play significant roles in limiting tumor growth. It has been revealed that the induction of endogenous IFN expression is one of the key mechanisms for successful IFN therapy. However, recent studies have shown that the efficacy of type I IFN therapy has limitations in the clinical treatment of certain tumors, including hepatocellular carcinoma (HCC). It ha...

ژورنال: کومش 2022

Introduction: Interferon (IFN) was first introduced by Isaacs and Linddeman in 1957. It referred to a factor that could cause inhibition in the growth of the live influenza virus. Interferons are intracellular proteins that are involved in many cellular processes such as growth, proliferation, differentiation, metabolism of the extracellular matrix, apoptosis, and regulating immune responses. T...

بافنده , یوسف, باقری لنکرانی , کامران, صابری فیروزی , مهدی,

Background and purpose: About 200,000 of Iranian population are infected with Hepatitis C Virus. On the basis of Iranian consensus on management of chronic hepatitis C (CHC) infection in 2004, combination therapy with conventional α-Interferon (IFN) plus Ribavirin is the first therapeutic choice in CHC patients. Data are limited on treatment response rate in most areas of the country. To asse...

افشین فتحی, , غلامحسین فلاحی, , مینا ایزدیار, ,

Background: Major thalassemia is relatively common in Iran and in looking of their need to recurrent transfusion their high risk for acquisition of HCV is revealed. These patients also suffer form liver hemosiderosis that accelerate disease excursion to cirrhosis and hepatocellular carcinoma. In this study combined therapy with interferon and amantadin has been evaluated. Methods: This prospe...

2012
Hideyuki Konishi Koichi Okamoto Yusuke Ohmori Hitoshi Yoshino Hiroshi Ohmori Motooki Ashihara Yuichi Hirata Atsunori Ohta Hiroshi Sakamoto Natsuko Hada Asao Katsume Michinori Kohara Kazumi Morikawa Takuo Tsukuda Nobuo Shimma Graham R. Foster William Alazawi Yuko Aoki Mikio Arisawa Masayuki Sudoh

Most acute hepatitis C virus (HCV) infections become chronic and some progress to liver cirrhosis or hepatocellular carcinoma. Standard therapy involves an interferon (IFN)-α-based regimen, and efficacy of therapy has been significantly improved by the development of protease inhibitors. However, several issues remain concerning the injectable form and the side effects of IFN. Here, we report a...

Journal: :iranian journal of immunology 0
mansour salehi department of genetics and molecular biology, school of medicine, school of medicine, isfahan university of medical sciences, isfahan, iran bahram bagherpour department of genetics and molecular biology, school of medicine, school of medicine, isfahan university of medical sciences, isfahan, iran vahid shayghannejad department of neurology, school of medicine, isfahan university of medical sciences, school of medicine, isfahan university of medical sciences, isfahan, iran farzaneh mohebi department of microbiology, islamic azad university, school of medicine, isfahan university of medical sciences, isfahan, iran rasool jafari department of parasitology and mycology, school of medicine, isfahan university of medical sciences, isfahan, iran

background: management of multiple sclerosis (ms) is based on the usage of immunosuppressive and immune-modulating medications. cytokines play an important role in the pathogenesis of ms. objective: to evaluate the effects of rapamycin on the concentrations of th1/th2/th17 serum cytokines in patients with ms. methods: six patients with relapsing remitting ms as a case group and 6 healthy indivi...

2004
Akira Sato Hiroshi Suzuki Hiroshi Mizuno Toshiya Ishii Izumi Sato Tomonari Tominaga Michihiro Suzuki Akira Nikai

In order to determine the most appropriate interferon (IFN) therapy according to patient background and to evaluate the efficacy of twice-daily IFN-β induction therapy (β2 therapy), 320 patients with chronic hepatitis C who underwent various IFN monotherapy regimens were retrospectively analyzed. Sustained virological response (SVR) and biochemical response (BR) rates were calculated with respe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید